JP2008510693A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510693A5
JP2008510693A5 JP2007526570A JP2007526570A JP2008510693A5 JP 2008510693 A5 JP2008510693 A5 JP 2008510693A5 JP 2007526570 A JP2007526570 A JP 2007526570A JP 2007526570 A JP2007526570 A JP 2007526570A JP 2008510693 A5 JP2008510693 A5 JP 2008510693A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
compound
ring
carbocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007526570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510693A (ja
Filing date
Publication date
Priority claimed from GBGB0418643.3A external-priority patent/GB0418643D0/en
Application filed filed Critical
Publication of JP2008510693A publication Critical patent/JP2008510693A/ja
Publication of JP2008510693A5 publication Critical patent/JP2008510693A5/ja
Pending legal-status Critical Current

Links

JP2007526570A 2004-08-20 2005-08-19 アレーンルテニウム(ii)化合物及び癌の治療におけるそれらの使用 Pending JP2008510693A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0418643.3A GB0418643D0 (en) 2004-08-20 2004-08-20 Ruthenium (II) compounds
PCT/GB2005/003242 WO2006018649A1 (en) 2004-08-20 2005-08-19 Arene ruthenium (ii) compounds and their use in cancer therapy

Publications (2)

Publication Number Publication Date
JP2008510693A JP2008510693A (ja) 2008-04-10
JP2008510693A5 true JP2008510693A5 (https=) 2008-09-25

Family

ID=33042406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526570A Pending JP2008510693A (ja) 2004-08-20 2005-08-19 アレーンルテニウム(ii)化合物及び癌の治療におけるそれらの使用

Country Status (12)

Country Link
EP (1) EP1786412A1 (https=)
JP (1) JP2008510693A (https=)
KR (1) KR20070060091A (https=)
CN (1) CN101043885A (https=)
AU (1) AU2005273726A1 (https=)
BR (1) BRPI0514430A (https=)
CA (1) CA2578280A1 (https=)
GB (1) GB0418643D0 (https=)
MX (1) MX2007002099A (https=)
NO (1) NO20071481L (https=)
WO (1) WO2006018649A1 (https=)
ZA (1) ZA200702093B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006017594A1 (de) * 2006-04-13 2007-10-18 Wacker Chemie Ag Neuartige Ru-Komplexe, deren Herstellung und Verwendung
US9018199B2 (en) 2006-05-09 2015-04-28 Ecole Polytechnique Federale De Lausanne (Epfl) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0711849D0 (en) * 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
EP2067771A1 (en) 2007-12-03 2009-06-10 EPFL Ecole Polytechnique Fédérale de Lausanne Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
EP2409697A1 (en) 2010-07-20 2012-01-25 Université de Neuchâtel Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736152A1 (de) * 1997-08-14 1999-02-18 Martin Wehlan Azido-Aziridinkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2003512471A (ja) * 1999-10-27 2003-04-02 ユニバーシティ コート, エディンバラ大学 窒素および配位子を含む癌治療用の半サンドイッチ状ルテニウム(ii)化合物
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds

Similar Documents

Publication Publication Date Title
EP4328229A3 (en) Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof
JP2010524932A5 (https=)
JP2006515858A5 (https=)
JP2010504286A5 (https=)
JP2019518766A5 (https=)
JP2004525150A5 (https=)
TW200637869A (en) The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
JP2019532928A5 (https=)
JP2016534134A5 (https=)
GB201201744D0 (en) Novel compounds
EP4467549A3 (en) Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
JP2018536648A5 (https=)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
BR0313078A (pt) Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou de um sal deste farmaceuticamente aceitável
JP2009511508A5 (https=)
JP2011219498A5 (https=)
JP2014524441A5 (https=)
EP4606427A3 (en) Tricyclic fused heterocyclic pde3/4 dual inhibitor and use thereof
JP2016501185A5 (https=)
JP2015537017A5 (https=)
JP2020500182A5 (https=)
CR20200418A (es) Inhibidores de orginasa y sus mètodos de uso antecedentes
JP2016537382A5 (https=)
JP2012512863A5 (https=)
JP2017517565A5 (https=)